WJ Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$556K Sell
605
-1
-0.2% -$1.01K 0.26% 50
2025
Q4
$651K Hold
606
0.29% 46
2025
Q3
$523K Sell
606
-406
-40% -$302K 0.23% 50
2025
Q2
$789K Hold
1,012
0.25% 57
2025
Q1
$836K Sell
1,012
-80
-7% -$66.6K 0.3% 50
2024
Q4
$843K Sell
1,092
-4,664
-81% -$3.86M 0.29% 48
2024
Q3
$5.1M Buy
5,756
+1,054
+22% +$948K 1.8% 18
2024
Q2
$4.26M Buy
4,702
+1,552
+49% +$1.24M 1.55% 19
2024
Q1
$2.45M Buy
3,150
+906
+40% +$645K 0.98% 27
2023
Q4
$1.31M Buy
2,244
+540
+32% +$315K 0.57% 37
2023
Q3
$915K Buy
1,704
+904
+113% +$466K 0.44% 34
2023
Q2
$375K Buy
+800
New +$335K 0.18% 48
2023
Q1
Sell
-600
Closed -$220K 61
2022
Q4
$220K Buy
+600
New +$213K 0.13% 54
2022
Q3
Sell
-700
Closed -$226K 55
2022
Q2
$226K Buy
+700
New +$210K 0.16% 47

Other funds holding LLY

WJ Wealth Management's LLY Position: Q1 2026 in Review

WJ Wealth Management reduced its Eli Lilly (LLY) stake by 0.17% in Q1 2026, selling an estimated $1.01K and leaving 605 shares worth $556K. The position accounts for 0.26% of the portfolio, ranked #50.

WJ Wealth Management first reported a position in LLY in Q2 2022 and has held it in 14 quarters since. The position peaked at $5.1M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • WJ Wealth Management held 605 shares of Eli Lilly worth $556K as of Q1 2026.
  • WJ Wealth Management sold 1 Eli Lilly share in Q1 2026, an estimated $1.01K.
  • Eli Lilly made up 0.26% of WJ Wealth Management's portfolio in Q1 2026, its #50 holding.
  • WJ Wealth Management first reported a position in Eli Lilly in Q2 2022 and has held it in 14 quarters since.
  • WJ Wealth Management's Eli Lilly position peaked at $5.1M in Q3 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on WJ Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.